A liver biopsy is an outpatient procedure that your doctor may recommend to diagnose an underlying medical condition. The procedure may cause pain, but it’s usually short lasting. Many liver biopsies ...

Expert clinicians remark on the current role of the liver biopsy in the diagnosis of advanced fibrosis due to nonalcoholic steatohepatitis and highlight considerations for utilizing newer, noninvasive ...

Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly accurate, sensitive, and specific for both NASH ...

The majority of reviews and editorials on this topic have been authored by hepatologists, rather than pathologists. This is appropriate because it is the clinician who is charged with evaluating the ...

The popularity of noninvasive options to diagnose liver disease has been growing, but are there times when more traditional methods like liver biopsy are still needed for a precise diagnosis? Medical ...

Dorothy M. M. Kersten Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Medical Director, Liver Transplantation Program, Cincinnati Children's Hospital Medical ...

Please provide your email address to receive an email when new articles are posted on . Agile scores had the highest predictive value and classified fewer patients in the intermediate-risk group vs.

NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, October is Liver Awareness Month – how a biopsy helps diagnose liver diseases, why fatty liver disease is now on the rise, and how it can ...

IRVINE & TEMPLE CITY, Calif.--(BUSINESS WIRE)--Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), today ...

Cirrhosis creates scars that damage your liver. This damage can prevent this vital organ from doing important jobs like helping with digestion and removing toxins from your body. The sooner your ...

The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...